GLF
PFE icon

Groupe la Francaise’s Pfizer PFE Stock Holding History

Groupe la Francaise’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Hold
37,000
– – 0.01% 277
2025
Q4 		$921K Buy
37,000
+22,000
+147% +$555K 0.01% 275
2025
Q3 		$382K Hold
15,000
– – 0.01% 374
2025
Q2 		$364K Buy
+15,000
New +$350K 0.01% 341

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Groupe la Francaise's PFE Position: Q1 2026 in Review

Groupe la Francaise reduced its Pfizer (PFE) stake by 7.1% in Q1 2026, selling an estimated $37.2K and leaving 18,173 shares worth $476K. The position accounts for 0.01% of the portfolio, ranked #318.

Groupe la Francaise first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.97M in Q1 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Groupe la Francaise held 18,173 shares of Pfizer worth $476K as of Q1 2026.
  • Groupe la Francaise sold 1,399 Pfizer shares in Q1 2026, an estimated $37.2K.
  • Pfizer made up 0.01% of Groupe la Francaise's portfolio in Q1 2026, its #318 holding.
  • Groupe la Francaise first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Groupe la Francaise's Pfizer position peaked at $3.97M in Q1 2025.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.